Revitalizing Pharmaceutical Industry: Overcoming Shortages, Brain Drain, and Education Deficits
In the realm of healthcare, Zydus Therapeutics has made significant strides with the positive results from the EPICS-III Phase 2(b)/3 Trial. The clinical research, conducted by Zydus Therapeutics, has shown promising success, as the company reported positive topline results. This trial is a significant step forward in the development of treatments for various conditions.
Meanwhile, in the field of women and child healthcare, two prominent entities, Mahajan Imaging & Labs and Fortis La Femme, have joined forces. The partnership aims to improve healthcare services for women and children.
Elsewhere, SetPoint Medical, a company specializing in neuromodulation therapies, has received funding. According to GlobalData, this investment indicates a growing confidence in neuromodulation approaches for autoimmune conditions. However, there is no publicly available information about when SetPoint Medical announced funding for neuromodulation in autoimmune diseases.
On the technology front, Dell Technologies has highlighted India's progress in AI adoption. The company credits leadership from both the government and industry for this advancement.
In addition, the ABDM 2.0 southern region consultation meeting was organized by NHA and held at IIITH. The meeting was a significant step towards the digitization of health records and the advancement of the healthcare sector in India.
Lastly, there has been no further information provided about a potential partnership between Novo Nordisk and Apollo Clinics. As more information becomes available, we will keep you updated.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
